Save your place

Sign in to WhoBought

Please try again later.

BridgeBio Pharma, Inc. (BBIO) institutional ownership

Latest close $82.66 Jul 22, 2026
Market cap$9.0B 52-week range SectorHealthcare
Funds holding · Q1 2026
446
reported BBIO position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
260 buyers · 186 sellers

BridgeBio Pharma, Inc. (BBIO) price and institutional activity

Dates

Q1 2026

$0 bought by 260 investors
Citadel Advisors LLCJanus Henderson Group PLC +258 more
$0 sold by 186 investors
Brooklands Fund Management LtdViking Global Investors LP +184 more
Bought Sold Totals per quarter; hover a bar for the names.

BridgeBio Pharma, Inc. (BBIO) institutional activity · 446

Investor Type Est. change Change Δ Own Date
Brooklands Fund Management Ltd · Exited
Change −2.8M Δ Own −100.0% Date Q1 2026
Brooklands Fund Management Ltd Exited· Q1 2026 −2.8M −100.0% Q1 2026
Viking Global Investors LP · Reduced
Change −2.6M Δ Own −17.7% Date Q1 2026
Viking Global Investors LP Reduced· Q1 2026 −2.6M −17.7% Q1 2026
Citadel Advisors LLC Added· Q1 2026 +2.5M +354.6% Q1 2026
Janus Henderson Group PLC · Added
Change +2.2M Date Q1 2026
Janus Henderson Group PLC Added· Q1 2026 +2.2M Q1 2026
Norges · Exited
Change −1.5M Δ Own −100.0% Date Q1 2026
Norges Exited· Q1 2026 −1.5M −100.0% Q1 2026
Jane Street Group, LLC · Added
Change +1.4M Date Q1 2026
Jane Street Group, LLC Added· Q1 2026 +1.4M Q1 2026
Two Sigma Advisers, LP · Exited
Change −1.4M Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −1.4M −100.0% Q1 2026
Polar Capital Holdings PLC · Added
Change +1.2M Date Q1 2026
Polar Capital Holdings PLC Added· Q1 2026 +1.2M Q1 2026
Two Sigma Investments, LP · Added
Change +1.2M Δ Own +60.3% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +1.2M +60.3% Q1 2026
Capital Research Global Investors · Reduced
Change −1.2M Δ Own −60.5% Date Q1 2026
Capital Research Global Investors Reduced· Q1 2026 −1.2M −60.5% Q1 2026
Paradigm Biocapital Advisors LP · Exited
Change −684K Δ Own −100.0% Date Q1 2026
Paradigm Biocapital Advisors LP Exited· Q1 2026 −684K −100.0% Q1 2026
Millennium Management LLC · Added
Change +597K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +597K Q1 2026
Driehaus Capital Management LLC · Reduced
Change −534K Date Q1 2026
Driehaus Capital Management LLC Reduced· Q1 2026 −534K Q1 2026
Diamant Asset Management, Inc. · New
Change +527K Date Q1 2026
Diamant Asset Management, Inc. New· Q1 2026 +527K Q1 2026
Geode · Added
Change +506K Date Q1 2026
Geode Added· Q1 2026 +506K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 446

Famous investor activity in BridgeBio Pharma, Inc. (BBIO)

BridgeBio Pharma, Inc. (BBIO) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Ellis Andrea · Director Sell −$1.4M
Price $84.00 Qty −17K Owned 23K ΔOwn −43.2% Trade date Jul 9, 2026 Filed date Jul 13, 2026
Ellis Andrea Director Sell $84.00 −17K −$1.4M 23K −43.2% Jul 9, 2026 Jul 13, 2026
Ellis Andrea · Director 2 operations 0
Price $16.75 Owned 17K Trade date Jul 9, 2026 Filed date Jul 13, 2026
Ellis Andrea Director 2 operations $16.75 0 17K Jul 9, 2026 Jul 13, 2026
Cook Jennifer E. · Director 2 operations −$13M
Price $84.00–$90.00 Qty −149K Owned 8K ΔOwn −94.7% Trade date Jul 9, 2026 Filed date Jul 13, 2026
Cook Jennifer E. Director 2 operations $84.00–$90.00 −149K −$13M 8K −94.7% Jul 9, 2026 Jul 13, 2026
Cook Jennifer E. · Director 6 operations 0
Price $8.45–$29.00 Owned 0 Trade date Jul 9, 2026 Filed date Jul 13, 2026
Cook Jennifer E. Director 6 operations $8.45–$29.00 0 0 Jul 9, 2026 Jul 13, 2026
Cook Jennifer E. · Director Sell −$2.6M
Price $70.00 Qty −37K Owned 8K ΔOwn −81.6% Trade date Jun 24, 2026 Filed date Jun 24, 2026
Cook Jennifer E. Director Sell $70.00 −37K −$2.6M 8K −81.6% Jun 24, 2026 Jun 24, 2026
Cook Jennifer E. · Director 4 operations 0
Price $8.45–$16.75 Owned 17K Trade date Jun 24, 2026 Filed date Jun 24, 2026
Cook Jennifer E. Director 4 operations $8.45–$16.75 0 17K Jun 24, 2026 Jun 24, 2026
Cook Jennifer E. · Director Sell −$151K
Price $68.57 Qty −2K Owned 8K ΔOwn −20.8% Trade date Jun 23, 2026 Filed date Jun 24, 2026
Cook Jennifer E. Director Sell $68.57 −2K −$151K 8K −20.8% Jun 23, 2026 Jun 24, 2026
Valantine Hannah · Director Sell −$151K
Price $68.57 Qty −2K Owned 9K ΔOwn −19.2% Trade date Jun 23, 2026 Filed date Jun 24, 2026
Valantine Hannah Director Sell $68.57 −2K −$151K 9K −19.2% Jun 23, 2026 Jun 24, 2026
Cook Jennifer E. · Director 2 operations 9K
Owned 5K Trade date Jun 22, 2026 Filed date Jun 24, 2026
Cook Jennifer E. Director 2 operations 9K 5K Jun 22, 2026 Jun 24, 2026
Valantine Hannah · Director Sell −$191K
Price $68.00 Qty −3K Owned 11K ΔOwn −19.7% Trade date Jun 22, 2026 Filed date Jun 24, 2026
Valantine Hannah Director Sell $68.00 −3K −$191K 11K −19.7% Jun 22, 2026 Jun 24, 2026
Valantine Hannah · Director 2 operations 0
Price $41.73 Owned 6K Trade date Jun 22, 2026 Filed date Jun 24, 2026
Valantine Hannah Director 2 operations $41.73 0 6K Jun 22, 2026 Jun 24, 2026
Valantine Hannah · Director 2 operations 9K
Owned 5K Trade date Jun 22, 2026 Filed date Jun 24, 2026
Valantine Hannah Director 2 operations 9K 5K Jun 22, 2026 Jun 24, 2026
Lo Andrew · Director 2 operations 9K
Owned 5K Trade date Jun 22, 2026 Filed date Jun 24, 2026
Lo Andrew Director 2 operations 9K 5K Jun 22, 2026 Jun 24, 2026
Homcy Charles J. · Director 2 operations 9K
Owned 5K Trade date Jun 22, 2026 Filed date Jun 24, 2026
Homcy Charles J. Director 2 operations 9K 5K Jun 22, 2026 Jun 24, 2026
Aguiar Eric · Director 2 operations 9K
Owned 5K Trade date Jun 22, 2026 Filed date Jun 24, 2026
Aguiar Eric Director 2 operations 9K 5K Jun 22, 2026 Jun 24, 2026
15 of 73
15 of 73 Sign in to continue to older insider transactions.

BridgeBio Pharma, Inc. (BBIO) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Viking Global Investors LP 25.1M
% of shares outstanding 13.4% Filing date Nov 6, 2024
Viking Global Investors LP 25.1M 13.4% Nov 6, 2024
KKR Genetic Disorder L.P. 25.3M
% of shares outstanding 13.4% Filing date Sep 17, 2024
KKR Genetic Disorder L.P. 25.3M 13.4% Sep 17, 2024
Vanguard Group Inc 12.8M
% of shares outstanding 7.4% Filing date Feb 13, 2024
Vanguard Group Inc 12.8M 7.4% Feb 13, 2024
Janus Henderson Group PLC 13.2M
% of shares outstanding 6.8% Filing date May 15, 2026
Janus Henderson Group PLC 13.2M 6.8% May 15, 2026
Blackrock, Inc. 12.9M
% of shares outstanding 6.8% Filing date Nov 12, 2024
Blackrock, Inc. 12.9M 6.8% Nov 12, 2024
BlackRock Inc. 10.2M
% of shares outstanding 5.8% Filing date Jan 29, 2024
BlackRock Inc. 10.2M 5.8% Jan 29, 2024
Kumar Neil 10.0M
% of shares outstanding 5.6% Filing date Feb 16, 2024
Kumar Neil 10.0M 5.6% Feb 16, 2024
Perceptive Advisors LLC 7.1M
% of shares outstanding 4.8% Filing date Feb 15, 2022
Perceptive Advisors LLC 7.1M 4.8% Feb 15, 2022
8 of 10

BridgeBio Pharma, Inc. (BBIO) ownership FAQ

Who owns BBIO?

446 reporting institutions disclosed BBIO position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.